Reproductive Health

Natural Cycles Partners with ŌURA on Body Temperature-based Fertility Tracking & Birth Control

ŌURA, the company behind the smart ring that delivers personalized health data, insights, and daily guidance, and Natural Cycles, the FDA-cleared birth control app have are teaming up: Starting today Natural Cycles users will now be able to sync temperature trend data straight from the Oura Ring, allowing them to track their temperature trends automatically while they sleep rather than manually taking…

Kindbody Acquires Gestational Surrogacy Agency ARR to Further Expand Its Continuum of Care

Kindbody, a leading fertility clinic network and family-building benefits provider for employers offering comprehensive virtual and in-person care, announced today the acquisition of Chicago-based Alternative Reproductive Resources (ARR), a leading gestational surrogacy agency. The acquisition will bring gestational surrogacy in-house, delivering a seamless continuum of patient care. The ARR team will join Kindbody as part of its expanded KindEOS division, the company’s in-house…

Organon Teams Up with Cirqle Biomedical to Advance Non-Hormonal, On-Demand Contraception

Cirqle Biomedical is a pre-clinical stage life science company with the goal of developing a first-in-class non-hormonal contraceptive that can help address the demand from millions of women for an effective contraceptive with minimal side-effects. Cirqle Biomedical’s approach to contraception is based on engineering mucus to leverage the natural barrier properties of cervical mucus. Cirqle Biomedical was launched in 2019 in Copenhagen,…

Twentyeight Health Expands Telehealth Services to Include Herpes Treatment

Twentyeight Health, a telehealth company providing affordable access and convenience for reproductive and sexual health, today announced that it will begin offering treatment for herpes.  “Since launching in 2018, women across the U.S. have relied on Twentyeight Health for birth control prescriptions and delivery. In the coming years, Twentyeight Health will be a bigger part of women’s sexual and reproductive care journies,…

The Lowdown Raises $2.5M in Seed Funding to Scale Its Contraception Review Platform in Europe

U.K.-based Contraception review platform The Lowdown has raised $2.5M in seed funding led by Speedinvest, who are joining joining existing investors Nina Capital, Calm/Storm VC, Entrepreneur First and four Atomico Angels. The Lowdown was founded by by Alice Pelton after suffering debilitating side effects from her contraception throughout her twenties. 78% of the 1 billion people worldwide who use contraception, experience side…

FemTec Health Acquires Ava Women, the Reproductive Health Company Known for Its FDA-Cleared Fertility Platform and Wearable

  FemTec Health, the company behind women’s health and wellness focused DTC brand Awesome Woman has acquired Ava, the digital diagnostics and therapeutics company specializing in women’s reproductive health. Backed by rigorous clinical trials, Ava has helped over 70,000 women get pregnant. Bringing together AI and clinical science, Ava’s FDA-cleared fertility platform is proven to help women conceive faster—reducing frustration and the need for costly, invasive…

OCON Healthcare Partners with BioGenuine to Market Its Products in China and Southeast Asia

OCON Healthcare is developing innovative women’s health solutions, inspired by women’s anatomy, that are specifically designed to be safe, comfortable, easily usable, and highly effective. Moving away from harmful oral formulations and debilitating hospital procedures, the company has developed a next-generation drug delivery platform the IUB Ballerine, IUB SEAD and IUB PRIMA to promote women’s uterine health safely and effectively. To further international…

Future Family Now Offers 0% Interest Rate Financing for Fertility Treatments

Future Family, the fertility finance platform pairing a modern fintech experience with client care and wellness support, announced that it will add a 0% interest rate fertility financing program to its offerings. This first-of-its-kind plan enables prospective parents to pay for high-cost fertility treatments with no additional interest for up to 12 months. This is a valuable alternative to large upfront payments…